Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: Impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 8, 2001, Pages 839-853

  Smith, Graeme B J ^a   Harper, Patricia A ^b,c   Wong, Judy M Y ^b   Lam, Maria S M ^b   Reid, Ken R ^a   Petsikas, Dimitri ^a   Massey, Thomas E ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; ETHOXYRESORUFIN; GLUTATHIONE TRANSFERASE; LYSINE; MICROSOME ENZYME;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CODON; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROSOME; PRIORITY JOURNAL; RECEPTOR GENE; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICROSOMES; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ARYL HYDROCARBON; SMOKING;

EID: 0034908211     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer
2. Drug metabolism polymorphisms as modulators of cancer susceptibility
3. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers
4. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma
5. Expression of CYP1A1 gene in patients with lung cancer: Evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas
6. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes
7. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients
8. Characterization of human lung microsomal cytochrome P-450IA1 and its role in the oxidation of chemical carcinogens
9. Immunohistochemical detection of pulmonary cytochrome P4501A and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients
10. Aryl hydrocarbon hydroxylase activity in human lung tissue: In relation to cigarette smoking and lung cancer
11. Ah receptor mediating induction of aryl hydrocarbon hydroxylase: Detection in human lung by binding of 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin
12. Interindividual difference in expression of human Ah receptor and related P450 genes
13. Polymorphic forms of the Ah receptor and induction of the CYP1A1 gene
14. Expression of pulmonary cytochrome P450IA1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer
15. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: Results from a case-control multicenter study on lung cancer patients
16. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene
17. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene
18. Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues
19. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose
20. 1450) gene: Lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population
21. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes
22. Point-mutational MSPI, and Ile-Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population
23. Polycyclic aromatic hydrocarbon-DNA adducts and the CYP1A1 restriction fragment length polymorphism
24. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer
25. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population
26. Lung cancer, race, and a CYP1A1 genetic polymorphism
27. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: A study on host factors in relation to age at onset, gender and histological cancer types
28. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: Exon-7 mutation (4889 A to G) and a T to C mutation in the 3′-flanking region
29. Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer
30. Cytochrome P-450IA1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil
31. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro
32. Assessment of cancer susceptibility in humans by use of genetic polymorphisms in carcinogen metabolism
33. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population
34. Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation
35. CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil
36. Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence
37. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility
38. CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population
39. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility
40. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans
41. Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients
42. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens
43. Association of Ile462Va1 (Exon 7) polymorphism of cytochrome P450 IA 1 with lung cancer in the Asian population: Further evidence from a case-control study in Okinawa
44. Lung cancer risk and CYP1A1 genotype in African Americans
45. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women
46. Polymorphism analysis of the CYP1A1 locus in Koreans: Presence of the solitary m2 allele
47. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients
48. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients
49. Gender differences in genetic susceptibility for lung cancer
50. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma
51. CYP1A1 1462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China
52. The role of ethnicity in cancer susceptibility gene polymorphism: The example of CYP1A1
53. Human CYP1A1 gene: Cosegregation of the enzyme inducibility phenotype and an RFLP
54. Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs
55. Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene
56. Relationship between genotype and function of the human CYP1A1 gene
57. The CYP1A1 gene and cancer susceptibility
58. Functional significance of different human CYP1A1 genotypes
59. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans
60. 1462V mutation in the human CYP1A1 gene: Lack of correlation with either the Msp I kb (M2) allele or CYP1A1 inducibility in a three-generation family of East Mediterranean descent
61. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene
62. 462: Assessment of a role for the rare allele in carcinogenesis
63. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility
64. Variation in induced CYP1A1 levels: Relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms
65. Allelic variants of human cytochrome P450 1A1 (CYP1A1): Effect of T461N and 1462V substitutions on steroid hydroxylase specificity
66. Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8- dihydrodiol by human CYP1A1 variants
67. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes
68. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo
69. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTMI*0/*0 genotypes
70. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTMI genotypes in lung patients
71. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: Correlation with lung DNA adduct levels
72. DNA adduct level in lung tissue may act as a risk biomarker of lung cancer
73. Contribution of genetic and nutritional factors to DNA damage in heavy smokers
74. Localization of CYP1A1 mRNA in human lung by in situ hybridization: Comparison with immunohistochemical findings
75. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer
76. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer
77. p53 gene mutations, and CYP1A1 and GSTM1 genotypes in pulmonary squamous cell carcinomas
78. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer
79. Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland
80. Influence of polymorphism at p53, CYP1A1 and GSTM1 loci on p53 mutation and association of p53 mutation with prognosis in lung cancer
81. A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility
82. Genetic polymorphism of induction of CYP1A1 (EROD) activity
83. Polymorphisms of human Ah receptor gene are not involved in lung cancer
84. Human Ah receptor (AHR) gene: Localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility
85. Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro
86. 1 in human lung: Differential cellular distribution and lack of significance of the GSTM1 genetic polymorphism
87. Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription
88. Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French population
89. 6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains
90. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer
91. Genetic risk and carcinogen exposure: A common inherited detect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer
92. Characterization of xenobiotic-metabolizing enzyme expression in human bronchial mucosa and peripheral lung tissues
93. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells
94. Tumor-specific expression of cytochrome P450 CYP1B1
95. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1
96. 1 in rabbit lung and liver microsomes
97. 1 in human lung
98. Protein measurement with the folin phenol reagent
99. Ethoxyresorufin: Direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene
100. Absence of induction of aryl hydrocarbon hydroxylase in mice after topical application of beclomethasone dipropionate
101. Induction of cytochrome P4501A genes (CYP1A) by omeprazole in the human alimentary tract
102. Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole
103. Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution
104. CYP1A1 polymorphisms and lung cancer risk: A metaanalysis
105. Expression and polymorphism of glutathione S-transferase in human lungs: Risk factors in smoking related lung cancer
106. Induction of the monooxygenase enzyme system in human lung
107. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States
108. Metabolism of benzo(a)pyrene by human lung microsomal fractions
109. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls
110. Long lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: A case control study on lung cancer patients
111. Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi
112. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer
113. An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes
114. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients
115. In vivo age-related changes in hepatic drug-oxidizing capacity in humans
116. Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions
117. Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver
118. Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer
119. Polymorphism in CYP1A1 and CYP2D6 genes: Possible association with susceptibility to lung cancer